ConductScience.org, home

Paper36901938

Experimental Models to Study Epithelial-Mesenchymal Transition in Proliferative Vitreoretinopathy.

Datlibagi A and 5 others. Int J Mol Sci, 2023. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Experimental Models to Study Epithelial-Mesenchymal Transition in Proliferative Vitreoretinopathy. Papers, record 36901938. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36901938

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Experimental Models to Study Epithelial-Mesenchymal Transition in Proliferative Vitreoretinopathy.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
4.66
iCite
Revised in PubMed
2023-03-14
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Datlibagi AAzinehttps://orcid.org/0000-0003-0049-9983
2Zein-El-Din AAnna
3Frohly MMaxime
4Willermain FFrançois
5Delporte CChristinehttps://orcid.org/0000-0003-0385-5824
6Motulsky EEliehttps://orcid.org/0000-0002-8708-4694

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Vitreoretinopathy, ProliferativeMajor topic
Humans
Mice
Rats
Animals
Rabbits
Swine
Epithelial-Mesenchymal Transition
Endothelial Cells
Retinal Pigment Epithelium
Disease Models, Animal

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CDR J.0128.23Fund for Scientific ResearchPubMed
Fonds Erasme pour la recherche médicalePubMed
Fund IRIS-Research managed by the King Baudouin FoundationPubMed

Source PubMed

Download CSV of grants

References142

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123341014Inhibition of PVR with a tyrosine kinase inhibitor, dasatinib, in the swine.Invest Ophthalmol Vis Sci2013https://conductscience.org/library/papers/23341014PubMed
225829415A Novel Approach of Daunorubicin Application on Formation of Proliferative Retinopathy Using a Porous Silicon Controlled Delivery System: Pharmacodynamics.Invest Ophthalmol Vis Sci2015https://conductscience.org/library/papers/25829415PubMed
333953964The Role of Intravitreal Anti-VEGF Agents in Rabbit Eye Model of Open-Globe Injury.J Ophthalmol2021https://conductscience.org/library/papers/33953964PubMed
432334405Epithelial-Mesenchymal Transition in Cancer: A Historical Overview.Transl Oncol2020https://conductscience.org/library/papers/32334405PubMed
510657752Combined pharmacologic therapy in a rabbit model of proliferative vitreoretinopathy (PVR).Ophthalmic Res2000https://conductscience.org/library/papers/10657752PubMed
618599521Potent inhibition of cicatricial contraction in proliferative vitreoretinal diseases by statins.Diabetes2008https://conductscience.org/library/papers/18599521PubMed
725152359Plasma membrane protein polarity and trafficking in RPE cells: past, present and future.Exp Eye Res2014https://conductscience.org/library/papers/25152359PubMed
834926193Upregulation of ASPP2 expression alleviates the development of proliferative vitreoretinopathy in a rat model.Int J Ophthalmol2021https://conductscience.org/library/papers/34926193PubMed
918926819Targeting of integrin-linked kinase with a small interfering RNA suppresses progression of experimental proliferative vitreoretinopathy.Exp Eye Res2008https://conductscience.org/library/papers/18926819PubMed
1030336127Rapid differentiation of the human RPE cell line, ARPE-19, induced by nicotinamide.Exp Eye Res2019https://conductscience.org/library/papers/30336127PubMed
1134283209Activated Blood Coagulation Factor X (FXa) Contributes to the Development of Traumatic PVR Through Promoting RPE Epithelial-Mesenchymal Transition.Invest Ophthalmol Vis Sci2021https://conductscience.org/library/papers/34283209PubMed
1216419035Intraocular injection of an aptamer that binds PDGF-B: a potential treatment for proliferative retinopathies.J Cell Physiol2006https://conductscience.org/library/papers/16419035PubMed
1315718827Effects of retinoic acid on retinal pigment epithelium from excised membranes from proliferative vitreoretinopathy.J Ocul Pharmacol Ther2005https://conductscience.org/library/papers/15718827PubMed
1429532788Inhibitory Effects of Plumbagin on Retinal Pigment Epithelial Cell Epithelial-Mesenchymal Transition In Vitro and In Vivo.Med Sci Monit2018https://conductscience.org/library/papers/29532788PubMed
1517294388Expression of proteins associated with cell-matrix adhesion in proliferative vitreoretinopathy designed by Dispase model.Eur J Ophthalmol2007https://conductscience.org/library/papers/17294388PubMed
1619324843Growth factors outside the PDGF family drive experimental PVR.Invest Ophthalmol Vis Sci2009https://conductscience.org/library/papers/19324843PubMed
1712883645IL-10 in vivo gene expression in a cell-induced animal model of proliferative vitreoretinopathy.Int J Mol Med2003https://conductscience.org/library/papers/12883645PubMed
1812202537Effect of 2'-benzoyl-oxycinnamaldehyde on RPE cells in vitro and in an experimental proliferative vitreoretinopathy model.Invest Ophthalmol Vis Sci2002https://conductscience.org/library/papers/12202537PubMed
1932818015Interleukin-6 promotes proliferative vitreoretinopathy by inducing epithelial-mesenchymal transition via the JAK1/STAT3 signaling pathway.Mol Vis2020https://conductscience.org/library/papers/32818015PubMed
2012707600The role of scleral buckle in experimental posterior penetrating eye injury.Retina2003https://conductscience.org/library/papers/12707600PubMed

See all 142 referencesDownload CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
42211205JNK inhibitor SP600125 alleviates TGF-β2-induced epithelial-mesenchymal transition in RPE cell via TGF-βR2/Smad2/3 and JNK/c-Jun pathway.Int J Ophthalmol2026https://conductscience.org/library/papers/42211205PubMed
41767322Vaccinia-related kinase 1/snail family transcriptional repressor 1 regulates epithelial-mesenchymal transition and inflammation in proliferative vitreoretinopathy.Int J Ophthalmol2026https://conductscience.org/library/papers/41767322PubMed
41529022A TGFB2/TNF-induced in vitro model of proliferative vitreoretinopathy (PVR) using ARPE-19 cells confirms nicotinamide as an inhibitor of EMT and VEGFA secretion.PLoS One2026https://conductscience.org/library/papers/41529022PubMed
41444271A novel accessible in vitro model of proliferative vitreoretinal diseases shows facilitated epithelial mesenchymal transition through aquaporin-1.Sci Rep2025https://conductscience.org/library/papers/41444271PubMed
41147690Deficiency of 2-Oxoglutarate Carrier (Slc25a11) Drives RPE Epithelial-to-Mesenchymal Transition and Exacerbates Subretinal Fibrosis in Neovascular Age-Related Macular Degeneration.Aging Cell2025https://conductscience.org/library/papers/41147690PubMed
41029102Pathogenic mechanisms and treatment advances in proliferative vitreoretinopathy: A review.Medicine (Baltimore)2025https://conductscience.org/library/papers/41029102PubMed
40536048Establishment of a novel alloxan-induced rabbit model exhibiting unique diabetic retinal neuropathy features assessed via ERG + VEP.Animal Model Exp Med2025https://conductscience.org/library/papers/40536048PubMed
40508210Tacrolimus Modulates TGF-β Signaling-Related Genes and MicroRNAs in Human Retinal Pigment Epithelial Cells Activated by Lipopolysaccharide.Int J Mol Sci2025https://conductscience.org/library/papers/40508210PubMed
40398745JAM-C prevents ocular fibrosis by suppressing the TAZ/KLF6 pathway.J Adv Res2026https://conductscience.org/library/papers/40398745PubMed
40371355Effect of methotrexate/dexamethasone combination on epithelial-mesenchymal transition and inflammation gene expression of human RPE cells in-vitro.Front Pharmacol2025https://conductscience.org/library/papers/40371355PubMed
40140939Leveraging AAV1-Rac1T17N to prevent experimental proliferative vitreoretinopathy.J Transl Med2025https://conductscience.org/library/papers/40140939PubMed
40119078Involvement of tdTomato-Tagged RPE cells in a mouse PVR model with enzymatically compromised retina.Sci Rep2025https://conductscience.org/library/papers/40119078PubMed
39612089As shown hesperidin suppresses TGF-β2-induced proliferation and epithelial-mesenchymal transition of retinal pigment epithelial cells.J Mol Histol2024https://conductscience.org/library/papers/39612089PubMed
39594586Short-Term Culture of Human Hyalocytes Retains Their Initial Phenotype and Displays Their Contraction Abilities.Cells2024https://conductscience.org/library/papers/39594586PubMed
39213375Survivin inhibition attenuates EGF-induced epithelial mesenchymal transformation of human RPE cells via the EGFR/MAPK pathway.PLoS One2024https://conductscience.org/library/papers/39213375PubMed
38623081Microfluidic Fabricated Liposomes for Nutlin-3a Ocular Delivery as Potential Candidate for Proliferative Vitreoretinal Diseases Treatment.Int J Nanomedicine2024https://conductscience.org/library/papers/38623081PubMed
38153753Transition to Chronic Fibrosis in an Animal Model of Retinal Detachment With Features of Proliferative Vitreoretinopathy.Invest Ophthalmol Vis Sci2023https://conductscience.org/library/papers/38153753PubMed
37906058Silibinin Prevents TGFβ-Induced EMT of RPE in Proliferative Vitreoretinopathy by Inhibiting Stat3 and Smad3 Phosphorylation.Invest Ophthalmol Vis Sci2023https://conductscience.org/library/papers/37906058PubMed
37407754Low-dose rosmarinic acid and thymoquinone accelerate wound healing in retinal pigment epithelial cells.Int Ophthalmol2023https://conductscience.org/library/papers/37407754PubMed

Download CSV of cited by

Genes14

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36901938

GET https://conductscience.org/api/papers/v1/36901938/references?page=2